Penumbra, Inc Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
Penumbra, Inc (PEN) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2023-02-23
- Penumbra, Inc impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2021-12-31 was $0.00.
- Penumbra, Inc impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2021-09-30 was $0.00.
- Penumbra, Inc impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2020-12-31 was $0.00.
- Penumbra, Inc impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2020-09-30 was $0.00.
- Penumbra, Inc impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2022 was $0.00.
- Penumbra, Inc impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Penumbra, Inc impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2020 was $2.50M.
- Penumbra, Inc impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2019 was $0.00.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-23 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 10-K · filed 2023-02-23 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $0.00 10-Q · filed 2021-11-03 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $2.50M derived: sum of 3 quarters · filed 2023-02-23 | $2.50M 10-K · filed 2023-02-23 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-02 | $2.50M derived: sum of 2 quarters · filed 2023-02-23 | $2.50M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $2.50M 10-K · filed 2023-02-23 | $2.50M 10-Q · filed 2021-08-09 | ||
| 2019-12-31 | $0.00 10-K · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $0.00 10-K · filed 2022-02-22 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $0.00 derived: sum of 2 quarters · filed 2020-11-02 | $0.00 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $0.00 10-Q · filed 2020-08-03 | ||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-07 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |